TRPM2 and melanoma: They have been utilized as experimental anticancer agents in cancer studies (including melanoma studies), and the specificity of their effects on cancer cell growth, proliferation, and cell death have been verified via TRPM2 RNAi knockdown techniques [26,27,28,71].